The Short-Term and Long-Term Effects of Cardiac Resynchronization Therapy in Heart Failure Patients

Objective to evaluate the short-term and long-term effects of cardiac resynchronization therapy in heart failure patients. Methods We continuous assessed forty-eight heart failure patients who underwent CRT implantation in our hospital from January 2008 to December 2012, evaluate/measure NYHA grade, left ventricular diastolic diameter (LVEDd), left ventricular ejection fraction (LVEF) and B-type natriuretic peptides (BNP) before cardiac resynchronization therapy and half year, one year, two years after cardiac resynchronization therapy. Results Compared to the results before cardiac resynchronization, half year, one year and two years later, NYHA grade, LVEF, LVEDd, BNP improved significantly (P 0.05). Conclusions CRT could improve cardiac function in patients with congestive heart failure, however, when we followed up the patients for two years, cardiac function did not improve further.

[1]  J. Cleland,et al.  Is the prognosis of heart failure improving? , 2000, European journal of heart failure.

[2]  D. Delurgio,et al.  Effect of Cardiac Resynchronization Therapy on Left Ventricular Size and Function in Chronic Heart Failure , 2003, Circulation.

[3]  John G F Cleland,et al.  Delivering the cumulative benefits of triple therapy to improve outcomes in heart failure: too many cooks will spoil the broth. , 2003, Journal of the American College of Cardiology.

[4]  J. Conti,et al.  Use of cardiac resynchronization therapy to optimize beta-blocker therapy in patients with heart failure and prolonged QRS duration. , 2005, The American journal of cardiology.

[5]  J. Daubert,et al.  The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[6]  Thomas P Cappola,et al.  Predictors of remodeling in the CRT era: influence of mitral regurgitation, BNP, and gender. , 2006, Journal of cardiac failure.

[7]  Catherine Klersy,et al.  Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. , 2006, Journal of the American College of Cardiology.

[8]  Wojciech Zareba,et al.  Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.

[9]  J. Blanc,et al.  Patients with non-ischaemic dilated cardiomyopathy and hyper-responders to cardiac resynchronization therapy: characteristics and long-term evolution. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[10]  David L Hayes,et al.  Left ventricular lead position for cardiac resynchronization: a comprehensive cinegraphic, echocardiographic, clinical, and survival analysis. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[11]  Cynthia Balion,et al.  BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review , 2014, Heart Failure Reviews.

[12]  Wojciech Zareba,et al.  Left Ventricular Ejection Fraction Normalization in Cardiac Resynchronization Therapy and Risk of Ventricular Arrhythmias and Clinical Outcomes: Results from the MADIT-CRT trial , 2014 .

[13]  Cynthia Balion,et al.  BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure , 2014, Heart Failure Reviews.

[14]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.

[15]  T. Imamura,et al.  Reverse Remodeling Achieved by Combination Therapy With High-Dose Beta Blocker and Cardiac Resynchronization. , 2015, International heart journal.

[16]  R. Borgquist,et al.  Prediction of clinical outcome in patients treated with cardiac resynchronization therapy - the role of NT-ProBNP and a combined response score , 2018, BMC Cardiovascular Disorders.